Jump Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Jump Financial’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.78M	Buy	+182,773	New	+$5.54M	0.05%	396
2026 Q1	–	Sell	-33,052	Closed	-$900K	–	1837
2025 Q4	$900K	Sell	33,052 -54,848	-62%	-$1.92M	0.01%	1021
2025 Q3	$3.53M	Buy	+87,900	New	+$3.31M	0.04%	519
2024 Q1	–	Sell	-16,240	Closed	-$362K	–	1859
2023 Q4	$362K	Buy	+16,240	New	+$364K	0.01%	1232
2023 Q1	–	Sell	-20,895	Closed	-$587K	–	1534
2022 Q4	$587K	Buy	+20,895	New	+$589K	0.03%	708
2022 Q2	–	Sell	-8,300	Closed	-$242K	–	1571
2022 Q1	$242K	Buy	+8,300	New	+$254K	0.01%	1190

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jump Financial's AGIO Position: Q2 2026 in Review

Jump Financial opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 182,773 shares worth $6.78M. The stake represents 0.05% of the portfolio and ranks #396 among its holdings. This is a return to the name: Jump Financial previously reported a position in AGIO as recently as Q4 2025.

Jump Financial first reported a position in AGIO in Q1 2022 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Jump Financial held 182,773 shares of Agios Pharmaceuticals worth $6.78M as of Q2 2026.
Agios Pharmaceuticals was a new Jump Financial position in Q2 2026.
Agios Pharmaceuticals made up 0.05% of Jump Financial's portfolio in Q2 2026, its #396 holding.
Jump Financial first reported a position in Agios Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.